Céline Labeyrie

Clinical spectrum and prognostic value of CNS MOG autoimmunity in adults

Álvaro Cobo‐Calvo, Anne Ruiz, Élisabeth Maillart et al. · Neurology · 2018 · 532 citations

Life Sciences, Neurology, Neuroscience +17

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14

Antibodies against the node of Ranvier: a real-life evaluation of incidence, clinical features and response to treatment based on a prospective analysis of 1500 sera

Émilien Delmont, Alexandre Brodovitch, Ludivine Kouton et al. · Journal of Neurology · 2020 · 109 citations · Full text

Life Sciences, Immunology, Pathology +5

Artificial intelligence to predict clinical disability in patients with multiple sclerosis using FLAIR MRI

Pauline Roca, Arnaud Attyé, L. Colas et al. · Diagnostic and Interventional Imaging · 2020 · 94 citations

Medicine, Computer Science, Neurology +15

Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis

Laura Obici, John L. Berk, Alejandra González‐Duarte et al. · Amyloid · 2020 · 72 citations · Full text

Medicine, Neurology, Pharmacotherapy +13